skip to main content
Language:

Results 1 - 10 of 13  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib
Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib
Material Type:
Article 		Add to e-Shelf

Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

Englinger, Bernhard ; Laemmerer, Anna ; Moser, Patrick ; Kallus, Sebastian ; Röhrl, Clemens ; Pirker, Christine ; Baier, Dina ; Mohr, Thomas ; Niederstaetter, Laura ; Meier‐Menches, Samuel M ; Gerner, Christopher ; Gabler, Lisa ; Gojo, Johannes ; Timelthaler, Gerald ; Senkiv, Julia ; Jäger, Walter ; Kowol, Christian R ; Heffeter, Petra ; Berger, Walter

International journal of cancer, 2020-09-15, Vol.147 (6), p.1680-1693 [Peer Reviewed Journal]

Full text available

Citations Cited by
2
Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074
Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074
Material Type:
Article 		Add to e-Shelf

Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Laemmerer, Anna ; Moser, Patrick ; Gabler, Lisa ; Groza, Diana ; Kowol, Christian R ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter

Cells (Basel, Switzerland), 2018-12-08, Vol.7 (12), p.259 [Peer Reviewed Journal]

Full text available

Citations Cited by
3
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Article 		Add to e-Shelf

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; van Schoonhoven, Sushilla ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; Jäger, Walter ; Kowol, Christian R ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter

Journal of experimental & clinical cancer research, 2017-09-07, Vol.36 (1), p.122-122

Full text available

Citations Cited by
4
Additional file 5: Figure S3. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 5: Figure S3. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Video 		Add to e-Shelf

Additional file 5: Figure S3. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
5
Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Video 		Add to e-Shelf

Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
6
Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Video 		Add to e-Shelf

Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
7
Additional file 3: Table S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 3: Table S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Datasets 		Add to e-Shelf

Additional file 3: Table S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
8
Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Text Resource 		Add to e-Shelf

Additional file 2: Figure S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
9
Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Text Resource 		Add to e-Shelf

Additional file 4: Figure S2. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by
10
Additional file 1: Table S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Additional file 1: Table S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Material Type:
Datasets 		Add to e-Shelf

Additional file 1: Table S1. of Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Englinger, Bernhard ; Kallus, Sebastian ; Senkiv, Julia ; Heilos, Daniela ; Gabler, Lisa ; Sushilla Van Schoonhoven ; Terenzi, Alessio ; Moser, Patrick ; Pirker, Christine ; Timelthaler, Gerald ; JäGer, Walter ; Kowol, Christian ; Heffeter, Petra ; Grusch, Michael ; Berger, Walter 2017

Full text available

Citations Cited by

Results 1 - 10 of 13  for Great Falls College MSU

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2)

Searching Remote Databases, Please Wait